Dr. Sun joined ELIQUENT in Jan. 2022. She is responsible for the preparation of nonclinical sections of regulatory dossiers, study reports review, as well as communication with clients regarding nonclinical study deficiencies and recommendations. After joining ELIQUENT, Dr. Sun has contributed to multiple projects for different indications including solid tumors, infectious disease, autoimmune diseases, etc.

Dr. Sun has 10+ years’ experience of hands-on research in the field of immunology, pharmacology and toxicology and has written high-quality publications in the areas of immunity, inflammation, and drug metabolism. Dr. Sun is fluent in both English and Mandarin and possesses extensive experience in writing and reviewing scientific publications.

Dr. Sun received her Ph.D. in Pharmacology and Toxicology from the University of Kansas before pursuing her postdoc study at the University of California, San Diego in the areas of liver fibrosis and hepatocellular carcinoma, and then at the University of Chicago in the area of innate lymphoid cell development.